BDBM683796 6-{4-[(1S,6R)-3,9- diazabicyclo[4.2.1] nonan-3-yl]-2- [(2,2-difluoro- hexahydro-1H- pyrrolizin-7a- yl)methoxy]-8- fluoroquinazolin-7- yl}-4-methyl-5- (trifluoromethyl)pyr- idin-2-amine::US20240217982, Example 12-4

SMILES Cc1cc(N)nc(-c2ccc3c(nc(OCC45CCCN4CC(F)(F)C5)nc3c2F)N2CC[C@H]3CC[C@@H](C2)N3)c1C(F)(F)F

InChI Key InChIKey=WGDUJSVHFOHZPL-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 683796   

TargetGTPase KRas [G12D](Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM683796(US20240217982, Example 12-4 | 6-{4-[(1S,6R)-3,9- d...)
Affinity DataIC50: 1.10E+3nMAssay Description:Recombinant GDP-loaded KRAS G12D (20 nM) was treated with compound at room temperature for 20 minutes in assay buffer (10 mM Hepes pH 7.4, 150 mM NaC...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent